The global empty capsules market value was USD 2.43 billion in 2023, driven by the increasing demand for capsule-based pharmaceutical and nutraceutical products across the globe. The market size is anticipated to grow at a CAGR of 7% during the forecast period of 2024-2032 to achieve a value of USD 4.47 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America is predicted to hold the major share of the empty capsules market during the forecast period, followed by Europe. This can be ascribed to the significant presence of a number of pharmaceutical giants with large capacities utilizing these capsules, along with the large presence of major capsule manufacturers with large production capacities in these regions. The rising emphasis on superior pharmaceutical products and generics by doctors and patients also increased the demand for empty capsules. As the pharmaceutical manufacturing sector in the Asia-Pacific region expands, several factors are expected to drive the impressive growth of empty capsules in the region. The rising patient pool in these regions also drives the market growth.
Empty capsules are stable shells that encapsulate medicines. They are administered in a variety of forms as dosage. Of these, the demand for vegetable/non-gelatine capsules is expected to increase in the coming years. This could be attributed to the rising preference among consumers for natural or non-animal origin capsules.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on type, the industry for empty capsules is segmented into:
Gelatin capsules are further divided on the basis of type into hard and soft gelatine.
On the basis of raw materials used in empty capsules, the industry is segmented into:
On the basis of functionality, the industry is segmented into:
On the basis of application, the industry is segmented into:
On the basis of end use, the industry is segmented into:
The regional markets for the empty capsules include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The growing popularity of capsules over other drug delivery forms has been the major driver of the market. Another pivotal driver is an increase in the strategic collaborations between empty capsule suppliers and gelatine manufacturers. The growing adoption of capsules among the increasing geriatric population is driving the market growth. Further, rapid developments in capsule delivery technologies are set to supplement the market growth. However, ethical concerns, fluctuations in price regarding gelatin, and strict regulations in the pharmaceutical industry are expected to decelerate the market growth.
Capsule delivery has experienced major technological developments over the years. These developments include improvement of capsule shells, capsule-sealing techniques, enhancing fill material, capsule systems to achieve modified drug release, and the encapsulation of different materials. These advancements have propelled the market growth of empty capsules in recent years. Development of technologies such as capsule-in-capsule to protect gastric-sensitive active ingredients allows for the improvement of gastrointestinal safety for patients who couldn’t receive capsule medication. An overall improved product development helped achieve significant penetration into wider populations. The Covid-19 pandemic is expected to be a major driver for this market for the forecast period.
However, ethical concerns, fluctuations in price regarding gelatine, and strict regulations in the pharmaceutical industry are expected to decelerate the market growth.
The report presents a detailed analysis of the following key players in the global empty capsules market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The comprehensive report looks into the macro and micro aspects of the industry. The report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
|Scope of the Report
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Type
|Breakup by Functionality
|Breakup by Application
|Breakup by End User
|Breakup by Region
|Report Price and Purchase Option
|Explore our purchase options that are best suited to your resources and industry needs.
|Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Empty Capsules Market Overview
3.1 Global Empty Capsules Market Historical Value (2017-2023)
3.2 Global Empty Capsules Market Forecast Value (2024-2032)
4 Global Empty Capsules Market Landscape
4.1 Global Empty Capsules Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Empty Capsules Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by End User
4.2.3 Analysis by Applications
5 Global Empty Capsules Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Empty Capsules Market Segmentation
6.1 Global Empty Capsules Market, by Type
6.1.1 Market Overview
6.1.2 Gelatin Capsules
6.1.3 Non-Gelatin Capsules
6.2 Global Empty Capsules Market, by Functionality
6.2.1 Market Overview
6.2.2 Immediate-Release Capsules
6.2.3 Sustained-Release Capsules
6.2.4 Delayed-Release Capsules
6.3 Global Empty Capsules Market, by Application
6.3.1 Market Overview
6.3.3 Antibacterial Drugs
6.3.4 Dietary Supplements
6.3.6 Antiflatulent Preparations
6.3.7 Antianemic Preparations
6.3.8 Anti-Inflammatory Drugs
6.3.9 Cardiovascular Therapy Drugs
6.3.10 Cough and Cold Drugs
6.4 Global Empty Capsules Market, by End User
6.4.1 Market Overview
6.4.2 Pharmaceutical Industry
6.4.3 Nutraceutical Industry
6.4.4 Cosmetic Industry and Research Laboratories
6.5 Global Empty Capsules Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Empty Capsules Market
7.1 Market Share by Country
7.2 United States of America
8 Europe Empty Capsules Market
8.1 Market Share by Country
8.2 United Kingdom
9 Asia Pacific Empty Capsules Market
9.1 Market Share by Country
10 Latin America Empty Capsules Market
10.1 Market Share by Country
11 Middle East and Africa Empty Capsules Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.5 South Africa
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
17 Supplier Landscape
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.3 Bright Pharma Caps
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.6 Comed Chemicals Limited.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.7 NATURAL CAPSULES LIMITED
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.8 Wuhan Carma Technology Co., Ltd.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.9 Goerlich Pharma GmbH
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.10 NecLife Lifesciences Ltd
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.11 HealthCaps India Ltd.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.12 Erawat Pharma Limited.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.14 SUHEUNG co., ltd.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.16 SNAIL PHARMA INDUSTRY
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisitions
17.18 Sunil Healthcare Limited
17.18.1 Financial Analysis
17.18.2 Product Portfolio
17.18.3 Demographic Reach and Achievements
17.18.4 Mergers and Acquisitions
17.19 H & CARE Incorp
17.19.1 Financial Analysis
17.19.2 Product Portfolio
17.19.3 Demographic Reach and Achievements
17.19.4 Mergers and Acquisitions
17.20 SHAOXING KANGKE CAPSULE CO., LTD
17.20.1 Financial Analysis
17.20.2 Product Portfolio
17.20.3 Demographic Reach and Achievements
17.20.4 Mergers and Acquisitions
18 Global Dental Laboratories Distribution Model (Additional Insight)
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Pricing Models and Strategies (Additional Insight)
21.2 Cost Model
21.2.1 Manufacturing Cost Analysis
21.2.2 Procurement Cost Analysis
21.2.3 Clinical Trial Cost Factors
21.3 Pricing Strategies
21.3.1 Competitor Pricing Analysis
21.3.2 Key Assessment of Product Attributes
21.3.3 Pricing Benchmark
*Additional insights provided are customisable as per client requirements.
The Empty Capsules Market was valued at USD 2.43 billion in 2023.
The market is expected to grow at a CAGR of 7% from 2024 to 2032 to reach a value of USD 4.47 billion by 2032.
The major drivers of the market include the growing industries and the rising demand for safer methods of drug delivery.
The empty capsules market is being aided by developments in the effectiveness of drugs as well as the introduction of new drugs to treat diseases.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Gelatine capsules and non-gelatine capsules are the leading types in the industry.
Porcine, bovine, bone, hydroxypropyl methylcellulose (HPMC), starch material, and others are the leading raw materials in the industry.
Immediate-release capsules, sustained-release capsules, delayed-release capsules are the leading functionalities in the industry.
Pharmaceutical, nutraceutical, cosmetics, and others are the leading end uses in the industry.
Based on application, the industry is segmented into antibiotic and antibacterial drugs, dietary supplements, antacid and anti-flatulent preparations, cardiovascular therapy drugs, among others.
The major players in the industry are Cupsugel (Lonza Group Ltd), ACG Group, Qualicaps (Mitsubishi Chemical Corporation), Capscanada (Lyfe Group Co.), Roxlor Group, and Suheung Co., Ltd., among others.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.